The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 07, 2017

Filed:

Apr. 16, 2003
Applicant:

Imtiaz Chaudry, Napa, CA (US);

Inventor:

Imtiaz Chaudry, Napa, CA (US);

Assignee:

Mylan Specialty LP, Canonsburg, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/12 (2006.01); A61K 31/56 (2006.01); A61K 31/573 (2006.01); A61K 9/00 (2006.01); A61K 31/57 (2006.01); A61K 31/7048 (2006.01); A61L 2/00 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/573 (2013.01); A61K 9/0043 (2013.01); A61K 31/56 (2013.01); A61K 31/57 (2013.01); A61K 31/7048 (2013.01); A61L 2/0035 (2013.01); A61K 9/10 (2013.01);
Abstract

Nasal pharmaceutical formulations comprising a drug substance having a specific particle size distribution profile are disclosed herein. Such profile provides increased bioavailability, increased efficacy or prolonged therapeutic effect of the drug substance when administered intranasally. The formulations of the present invention may comprise one or more corticosteroids having a specific particle size distribution profile. In a preferred embodiment, the corticosteroid is fluticasone or a pharmaceutically acceptable derivative thereof for the treatment of one or more symptoms of rhinitis. Preferably, the drug substance is fluticasone propionate. The formulations herein may be provided as an aqueous suspension suitable for inhalation via the intranasal route.


Find Patent Forward Citations

Loading…